Trial Site Detail
Drug: |
Nivolumab + Ipilimumab |
|||
|---|---|---|---|---|
Trial: |
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
UCLA's Jonsson Comprehensive Cancer Center10945 Le Conte Ave. |
Principal Investigator: |
Arun Singh, MD |
|---|---|
Contact: |
310-829-5471 asingh@mednet.ucla.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
UCLA's Jonsson Comprehensive Cancer Center Website: |
http://www.cancer.ucla.edu/Index.aspx?page=51 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.